TuHURA Biosciences Takes $650K Draw on $50M Revolving Credit Facility

What Happened

• TuHURA Biosciences, Inc. announced it drew an additional $650,000 on its existing revolving credit facility with Parkview Holdings One LLC. The Company originally entered the Loan Agreement on April 21, 2026. The revolving facility matures April 21, 2031 and has maximum availability of $50 million. The Company says the August 7, 2026 draw will be used for general corporate purposes.

Key Details

• Lender: Parkview Holdings One LLC.
• Facility size: up to $50,000,000 maximum revolving availability.
• New draw: $650,000 borrowed on August 7, 2026.
• Loan Agreement date / maturity: Agreement dated April 21, 2026; maturity April 21, 2031.
• Disclosure: Full Loan Agreement was previously filed as Exhibit 4.1 to TuHURA’s Form 8‑K on April 22, 2026. The filing also includes standard forward‑looking statement disclaimers.

Why It Matters

• The draw increases TuHURA’s near‑term cash resources and is intended for general corporate purposes, which can help fund operations and development while the company pursues other financing or milestones.
• Investors should note the facility’s size ($50M) and that future access depends on meeting loan conditions; the company warned of risks including potential inability to draw funds or that available funds may be insufficient.
• The lender is affiliated with the company’s largest stockholder, which the filing identifies as a potential conflict of interest to consider when evaluating governance and related‑party risk.